Quick Summary:
Navigate evolving market trends in the burgeoning Apoptosis industry with our comprehensive market research report. Uncover the key insights poised to shape the industry, forecasted to reach a substantial market size of US$6.6 billion by 2030, with our data-driven and cutting-edge market research methodologies that leave no stone unturned.
Discover which geographical markets hold the most promising opportunities, from the robust US arena, presently valued at US$1.4 billion, to the emerging Chinese market, predicted to exponentially grow at a CAGR of 3.6% in the next 8 years. Our report offers a clear pathway through these intricate landscapes, alongside an exhaustive analysis of key competitors and their standing in this dynamic industry. Take advantage of our unparalleled market intelligence to navigate these waters with confidence and seize the opportunities that lie ahead. We present the knowledge needed to make informed business decisions, ensuring your continued success in the ever-evolving apoptosis market.
Global Apoptosis Market to Reach $6.6 Billion by 2030
The global market for Apoptosis estimated at US$4.9 Billion in the year 2022, is projected to reach a revised size of US$6.6 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2022-2030. Assay Kits, one of the segments analyzed in the report, is projected to record 3.5% CAGR and reach US$3.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Reagents segment is readjusted to a revised 5.1% CAGR for the next 8-year period.
The U.S. Market is Estimated at $1.4 Billion, While China is Forecast to Grow at 3.6% CAGR
The Apoptosis market in the U.S. is estimated at US$1.4 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 3.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.5% and 2.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.Select Competitors (Total 11 Featured) -
- Abcam PLC
- BD Biosciences
- Bio-Rad Laboratories, Inc.
- BioTek Instruments, Inc.
- Biotium, Inc.
- Creative Bioarray
- Danaher Corporation
- GE Healthcare
- GeneCopoeia, Inc.
- Geno Technology Inc.
- Merck KGaA
- Novus Biologicals LLC
- PerkinElmer, Inc.
- Promega Corporation
- Sartorius AG
- Thermo Fisher Scientific, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Apoptosis?
What is the growth rate of the Global Market for Apoptosis?
What is the forecasted size of the Global Market for Apoptosis?
Who are the key companies in the Global Market for Apoptosis?
| Report Attribute | Details |
|---|---|
| No. of Pages | 72 |
| Published | November 2023 |
| Forecast Period | 2020 - 2027 |
| Estimated Market Value ( USD | $ 4.2 Billion |
| Forecasted Market Value ( USD | $ 5.6 Billion |
| Compound Annual Growth Rate | 4.2% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abcam PLC
- BD Biosciences
- Bio-Rad Laboratories, Inc.
- BioTek Instruments, Inc.
- Biotium, Inc.
- Creative Bioarray
- Danaher Corporation
- GE Healthcare
- GeneCopoeia, Inc.
- Geno Technology Inc.
- Merck KGaA
- Novus Biologicals LLC
- PerkinElmer, Inc.
- Promega Corporation
- Sartorius AG
- Thermo Fisher Scientific, Inc.
